These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37432123)

  • 1. Lipid A Modification and Metabolic Adaptation in Polymyxin-Resistant, New Delhi Metallo-β-Lactamase-Producing Klebsiella pneumoniae.
    Lu J; Han M; Yu HH; Bergen PJ; Liu Y; Zhao J; Wickremasinghe H; Jiang X; Hu Y; Du H; Zhu Y; Velkov T
    Microbiol Spectr; 2023 Aug; 11(4):e0085223. PubMed ID: 37432123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic responses of a New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae isolate to the combination of polymyxin B and chloramphenicol.
    Abdul Rahim N; Cheah SE; Johnson MD; Zhu Y; Yu HH; Sidjabat HE; Butler MS; Cooper MA; Fu J; Paterson DL; Nation RL; Boyce JD; Bergen PJ; Velkov T; Li J
    Int J Antimicrob Agents; 2020 Aug; 56(2):106061. PubMed ID: 32574791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Proteomics of Outer Membrane Vesicles from Polymyxin-Susceptible and Extremely Drug-Resistant Klebsiella pneumoniae.
    Hussein M; Jasim R; Gocol H; Baker M; Thombare VJ; Ziogas J; Purohit A; Rao GG; Li J; Velkov T
    mSphere; 2023 Feb; 8(1):e0053722. PubMed ID: 36622250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid A profiling and metabolomics analysis of paired polymyxin-susceptible and -resistant MDR Klebsiella pneumoniae clinical isolates from the same patients before and after colistin treatment.
    Aye SM; Galani I; Han ML; Karaiskos I; Creek DJ; Zhu Y; Lin YW; Velkov T; Giamarellou H; Li J
    J Antimicrob Chemother; 2020 Oct; 75(10):2852-2863. PubMed ID: 32696049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Metabolomics and Transcriptomics Reveal Multiple Pathways Associated with Polymyxin Killing in Pseudomonas aeruginosa.
    Han ML; Zhu Y; Creek DJ; Lin YW; Gutu AD; Hertzog P; Purcell T; Shen HH; Moskowitz SM; Velkov T; Li J
    mSystems; 2019; 4(1):. PubMed ID: 30637340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of Metabolic and Lipid Profiles in Polymyxin-Resistant Pseudomonas aeruginosa.
    Han ML; Zhu Y; Creek DJ; Lin YW; Anderson D; Shen HH; Tsuji B; Gutu AD; Moskowitz SM; Velkov T; Li J
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy of the Polymyxin-Chloramphenicol Combination against New Delhi Metallo-β-Lactamase-Producing
    Abdul Rahim N; Zhu Y; Cheah SE; Johnson MD; Yu HH; Sidjabat HE; Butler MS; Cooper MA; Fu J; Paterson DL; Nation RL; Boyce JD; Creek DJ; Bergen PJ; Velkov T; Li J
    ACS Infect Dis; 2021 Jun; 7(6):1584-1595. PubMed ID: 33834753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol.
    Abdul Rahim N; Cheah SE; Johnson MD; Yu H; Sidjabat HE; Boyce J; Butler MS; Cooper MA; Fu J; Paterson DL; Nation RL; Bergen PJ; Velkov T; Li J
    J Antimicrob Chemother; 2015 Sep; 70(9):2589-97. PubMed ID: 26023209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Polymyxin Combination with the Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-Producing Multidrug-Resistant Klebsiella pneumoniae.
    Lin YW; Abdul Rahim N; Zhao J; Han ML; Yu HH; Wickremasinghe H; Chen K; Wang J; Paterson DL; Zhu Y; Rao GG; Zhou QT; Forrest A; Velkov T; Li J
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparative Study of Outer Membrane Proteome between Paired Colistin-Susceptible and Extremely Colistin-Resistant Klebsiella pneumoniae Strains.
    Jasim R; Baker MA; Zhu Y; Han M; Schneider-Futschik EK; Hussein M; Hoyer D; Li J; Velkov T
    ACS Infect Dis; 2018 Dec; 4(12):1692-1704. PubMed ID: 30232886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymyxin Combinations Combat
    Bulman ZP; Chen L; Walsh TJ; Satlin MJ; Qian Y; Bulitta JB; Peloquin CA; Holden PN; Nation RL; Li J; Kreiswirth BN; Tsuji BT
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid A in outer membrane vesicles shields bacteria from polymyxins.
    Burt M; Angelidou G; Mais CN; Preußer C; Glatter T; Heimerl T; Groß R; Serrania J; Boosarpu G; Pogge von Strandmann E; Müller JA; Bange G; Becker A; Lehmann M; Jonigk D; Neubert L; Freitag H; Paczia N; Schmeck B; Jung AL
    J Extracell Vesicles; 2024 May; 13(5):e12447. PubMed ID: 38766978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis for the increased polymyxin susceptibility of Klebsiella pneumoniae strains with under-acylated lipid A.
    Velkov T; Soon RL; Chong PL; Huang JX; Cooper MA; Azad MA; Baker MA; Thompson PE; Roberts K; Nation RL; Clements A; Strugnell RA; Li J
    Innate Immun; 2013 Jun; 19(3):265-77. PubMed ID: 23008349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyxin resistance in Klebsiella pneumoniae: multifaceted mechanisms utilized in the presence and absence of the plasmid-encoded phosphoethanolamine transferase gene mcr-1.
    Nang SC; Han ML; Yu HH; Wang J; Torres VVL; Dai C; Velkov T; Harper M; Li J
    J Antimicrob Chemother; 2019 Nov; 74(11):3190-3198. PubMed ID: 31365098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic Insights to Combating NDM- and CTX-M-Coproducing Klebsiella pneumoniae by Targeting Cell Wall Synthesis and Outer Membrane Integrity.
    Smith NM; Boissonneault KR; Chen L; Petraitis V; Petraitiene R; Tao X; Zhou J; Lang Y; Kavaliauskas P; Bulman ZP; Holden PN; Cha R; Bulitta JB; Kreiswirth BN; Walsh TJ; Tsuji BT
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0052722. PubMed ID: 35924913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the networks controlling the antimicrobial-peptide-dependent induction of Klebsiella pneumoniae virulence factors.
    Llobet E; Campos MA; Giménez P; Moranta D; Bengoechea JA
    Infect Immun; 2011 Sep; 79(9):3718-32. PubMed ID: 21708987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate.
    Pitt ME; Cao MD; Butler MS; Ramu S; Ganesamoorthy D; Blaskovich MAT; Coin LJM; Cooper MA
    J Antimicrob Chemother; 2019 Mar; 74(3):582-593. PubMed ID: 30445429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic Changes of Klebsiella pneumoniae in Response to Colistin Treatment and
    Sun L; Rasmussen PK; Bai Y; Chen X; Cai T; Wang J; Guo X; Xie Z; Ding X; Niu L; Zhu N; You X; Kirpekar F; Yang F
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32229491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae.
    Velkov T; Deris ZZ; Huang JX; Azad MA; Butler M; Sivanesan S; Kaminskas LM; Dong YD; Boyd B; Baker MA; Cooper MA; Nation RL; Li J
    Innate Immun; 2014 May; 20(4):350-63. PubMed ID: 23887184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment.
    Zhu Y; Galani I; Karaiskos I; Lu J; Aye SM; Huang J; Yu HH; Velkov T; Giamarellou H; Li J
    J Infect; 2019 Oct; 79(4):312-321. PubMed ID: 31374222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.